Gorana Dasic M.D.

Gorana Dasic MD, MSc has an extensive work experience in the medical and pharmaceutical field. Gorana Dasic currently holds the position of VP, Global Medical Affairs Head at Kedrion Biopharma. Prior to this, they worked as an Advisor at FOUR from 2016 to 2023. Gorana Dasic also held various roles at Pfizer, including VP, Global Medical Affairs, Chronic Pain Lead from 2019 to 2022, Global Therapeutic Area Medical Affairs Team Leader, Rheumatology from 2017 to 2019, and Global Medical Lead/Team Leader, XELJANZ, Rheumatology from 2015 to 2017. Before Pfizer, they served as the Country Medical Head at Biogen from 2011 to 2015. Their earlier experience includes a position as Director, Clinical Development/Medical Affairs at GlaxoSmithKline from 1999 to 2009. Gorana Dasic began their career as a Senior Research Scientist at PLIVA in 1998. Prior to that, they worked as a Postdoctoral Scientist at the Glaxo Institute for Molecular Biology (Geneva) from 1996 to 1997. Gorana Dasic also worked as a Research Scientist at the Institute of Immunology from 1991 to 1996.

Gorana Dasic MD, MSc, completed their Medical School degree in Medicine at the University of Zagreb, Croatia from 1984 to 1991. Gorana Dasic also pursued further education, earning a Master of Science (MSc) degree in Biomedicine (Immunology) from the Faculty of Science at the University of Zagreb, Croatia between 1993 and 1996. In 2003-2004, they studied Pharmaceutical Medicine at the University of Wales, Cardiff, and in 2006, they completed a program in Strategic Marketing Essentials at The Wharton School. Furthermore, they obtained additional knowledge in Sustainability, Corporate and Social Responsibility from FGV - Fundação Getulio Vargas in 2011 and Project Management from Università Bocconi in 2001. Currently, they are pursuing a degree in Strategic Management in Business Administration and Management, General at Copenhagen Business School since 2016.